Monitoring of Donor/recipient T-cell Engraftment Kinetics in Myeloablative Allogeneic Stem Cell Transplantation Using Short Tandem Repeat Amplification from Cell Lysates

References

• Lapointe, C, Forest, L., Lussier, P., Busque, L., Lagace, R, Perreault, C, Roy, D.C. and Gyger, M. (1996) "Sequential analysis of early hematopoietic reconstitution following allogeneic bone marrow transplantation with fluorescence in situ hybridization (FISH)", Bone Marrow Transplantation 17, 1143–1148.
   PubMed Web of Science ®Google Scholar
• Butturini, A., Seeger, R.C. and Gale, R.P. (1986) "Recipient immune-competent T lymphocytes can survive intensive condition�ing for bone marrow transplantation", Blood 68, 954–956.
   PubMed Web of Science ®Google Scholar
• Korngold, R. and Sprent, J. (1983) "Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complex", Immunological Reviews 71, 5–29.
   PubMed Web of Science ®Google Scholar
• Lapp, W.S., Ghayur, T., Mendes, M., Seddik, M. and Seemayer, T.A. (1985) "The functional and histological basis for graft-versus-host disease", Immunological Reviews 88, 107–133.
   PubMed Web of Science ®Google Scholar
• Brochu, S., Baron, C., Hetu, F., Roy, D.C. and Perreault, C. (1995) "Oligoclonal expression of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras", Journal of Immunology 155, 5104–5114.
   PubMed Web of Science ®Google Scholar
• Reisner, Y., Ben-Bassat, I., Douer, D., Kaploon, A., Schwartz, E. and Ramot, B. (1986) "Demonstration of clonable alloreactive T-cells in a primate model for bone marrow transplantation", Proceedings of the National Academy of Sciences USA 83, 4012–4015.
   PubMed Web of Science ®Google Scholar
• Baker, M.B., Riley, R.L., Podack, E.R. and Levy, R.B. (1997) "Graft-versus-host disease associated with lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell mediated Fas-ligand function, but not perforin function", Proceedings of the National Academy of Sciences 94, 1366–1371.
   PubMed Web of Science ®Google Scholar
• Gyger, M., Baron, C., Forest, L., Lussier, P., Lagac�, R, Bisonette, L, B�langer, R., Bonny, Y., Busque, L. and Roy, D.C. (1998) "Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs-host disease", Experimental Hematology 26, 426–434.
   PubMed Web of Science ®Google Scholar
• Vogelsang, G., Hess, A.D., Berkman, A.W., Tutschka, PL, Farmer, E.R., Converse, PL and Santos, G.W. (1995) "An in vitro predictive test for graft versus host disease in patients with genotypically HLA-identical bone marrow transplants", New England Journal of Medicine 313, 645–650.
   Web of Science ®Google Scholar
• Bagot, M., Mary, J.Y., Heslan, M., Kuentz, M., Cordonnier, C, Vernant, LP, Dubertret, L. and Levy, LP. (1988) "The mixed epidermal cell lymphocyte-reaction is the most predictive factor of acute graft-versus-host disease in bone marrow graft recipients", British Journal of Haematology 70, 403–409.
   PubMed Web of Science ®Google Scholar
• Theobald, M., Nierle, T., Bunjes, D., Arnold, R. and Heimpel, H. (1992) "Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings", New England Journal of Medicine 327, 1613–1617.
   PubMed Web of Science ®Google Scholar
• Nierle, T., Bunjes, D., Arnold, R., Heimpel, H. and Theobald, M. (1993) "Quantitative assessment of posttransplant host-specific interleukin-2-secreting T-helper cell precursors in patients with and without acute graft versus host disease after allogeneic HLA-identical sibling bone marrow transplantation", Blood 81, 841–848.
   PubMed Web of Science ®Google Scholar
• Serrano, J., Roman, J., Sanchez, J., Jimenez, A., Castillejo, J.A., Herrera, C, Gonzales, M.G., Reina, L., Rodriquez, M.C., Alvarez, M.A., Maldonado, J. and Torres, A. (2000) "Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210BCR_ABL and pi90BCR~ABL after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and pi90 CR_ABL detection precede cytogenetic relapse", Blood 95, 2659–2665.
   PubMed Web of Science ®Google Scholar
• Winiarski, J., Gustafsson, A., Wester, D., Dalianis, T, Szydlo, R. and Goldman, J.M. (2000) "Follow-up of chimerism, including T-and B-lymphocytes and granulocytes in children more than one year after allogeneic bone marrow transplantation". Pediatr Transplant, 4, 123–9.
   PubMedGoogle Scholar
• Tutschka, P.J., Copeland, E.A. and Klein, J.P. (1987) "Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen", Blood 70, 1382–1388.
   PubMed Web of Science ®Google Scholar
• Chao, N.J., Schmidt, G.M., Niland, J.C., Amylon, M.D., Dagis, A.C., Long, G.D., Nademanee, A.P., Negrin, R.S., O'Donnell, M.R., Parker, P.M., Smith, E.P., Snyder, D.S., Stein, A.S., Wong, R.M., Blume, K.G. and Forman, S.J. (1993) "Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease", New England Journal of Medicine 329, 1225–1230.
   PubMed Web of Science ®Google Scholar
• Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C, Ben-Tal, O., Eldor, A. and Or, R. (1998) "Nonmyeloblative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases", Blood 91, 756–763.
   PubMed Web of Science ®Google Scholar
• Spitzer, T.R., McAfee, S., Sackstein, R., Colby, C, Toh, H.C., Multani, P., Saidman, S., Weymouth, D., Preffer, F, Poliquin, C, Foley, A., Cox, B., Andrews, D., Sachs, D. and Sykes, M. (2000) "Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloblative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies", Biology of Blood and Marrow Transplantation 6, 309–320.
   PubMed Web of Science ®Google Scholar